share_log

BTIG Maintains Buy on MDxHealth, Raises Price Target to $8

Moomoo 24/7 ·  Mar 7 07:27

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and raises the price target from $7 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment